LEP and cancer: To the best of our knowledge, the first pooled‐analysis that carried out an extensive evaluation of the G19A polymorphism in the LEP 5′‐UTR region with the risk of overall cancer was conducted in 2014.15 In our meta‐analysis, 13 publications involving 8059 cases and 11 930 controls were included.